3D-printed CBD tablets may offer more controlled drug release
Mechanistic Comparison of Semi-Solid Extrusion 3D-Printed Printlets and Hot-Moulded Tablets: Linking Polymer-API Interactions, Microstructure, and Dissolution of Plant-Based Formulations.
AI Summary
This study compared semi-solid extrusion 3D printing with conventional hot moulding for tablets containing plant-based active ingredients, including cannabidiol (CBD). Both methods produced tablets with similar dimensions and mass, but their strength, internal structure, and drug-release behaviour varied depending on the formulation.
The 3D-printed tablets were generally more porous and internally heterogeneous than moulded tablets, which helped liquids enter the tablets and allowed the active ingredients to diffuse out more readily. Their drug release reached approximately 95%. Formulations made with agar-pectin formed a denser, more cohesive structure and released their active ingredients more slowly, while gelatine-pectin produced a more porous matrix. In gelatine-pectin printlets, adding the active ingredients increased void volume from 1.15% to 8.77%. For cannabis products, the findings suggest that 3D printing could offer greater control over tablet structure and release, although this study examined release and formulation performance rather than effects in cannabis users.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.